TMFEBCapital

Todd Campbell

TMFEBCapital’s Activity

Yesterday

NL

Article

EBCapitalMarkets published an article 4:31 PM

Why Ariad Pharmaceuticals Rocketed More Than 40% Higher Today

Baxalta is trying to buy Ariad Pharmaceuticals, but a deal hasn't been finalized.

NL

Article

EBCapitalMarkets published an article 10:02 AM

Manic Markets: Healthcare Bargains Worth Buying

Industry Focus is sifting through the healthcare rubble to find your gems.

Wed Aug 26

NL

Article

EBCapitalMarkets published an article 4:15 PM

Cutting the Cord and Other Money-Saving Moves

You can save hundreds of dollars by ditching cable companies, switching car insurers, and avoiding pricey cellular contracts.

NL

Article

EBCapitalMarkets published an article 2:17 PM

3 Ways to Get Your Portfolio Ship-Shape

One Fool highlights steps investors should be taking during the recent market correction.

NL

Article

EBCapitalMarkets published an article 12:30 PM

Eli Lilly's Diabetes Drug May Halt Heart Disease

Eli Lilly's Jardiance was shown to reduce the risk of heart attack and stroke in diabetics.

NL

Article

EBCapitalMarkets published an article 10:07 AM

3 Little-Known Medtech Stocks Investors Ought To Consider

Masimo Corp, Abiomed, and DexCom may be worthy of long haul portfolios.

Tue Aug 25

NL

Article

EBCapitalMarkets published an article 10:43 AM

Bouncing Biotech? 3 Stocks To Buy

It may be time to consider buying Gilead Sciences, Celgene Corp, and Regeneron on sale.

Mon Aug 24

NL

Article

EBCapitalMarkets published an article 3:34 PM

Why Galena Biopharma Jumped 10% Today

Independent monitors are reducing cardiac monitoring in a key Galena Biopharma phase 3 trials.

Sat Aug 22

NL

Article

EBCapitalMarkets published an article 8:41 AM

BioMarin's Big Bet on Muscular Dystrophy Is Already Paying Off

BioMarin's drisaperson for DMD has just landed an FDA designation that could net the company a voucher worth hundreds of millions of dollars.

Thu Aug 20

NL

Article

EBCapitalMarkets published an article 3:43 PM

Valeant Bets Women's Viagra Is Worth More Than $1 Billion

Valeant is forking over $1 billion, plus milestones, to acquire the women's libido drug Addyi.

NL

Article

EBCapitalMarkets published an article 11:02 AM

Did AbbVie Just Make an Incredibly Brilliant Decision?

AbbVie just paid $350 million for a voucher that can shorten the wait for FDA approval of one of its drugs.

NL

Article

EBCapitalMarkets published an article 12:00 AM

Bull Or Bear? Biotech's Post-Earnings Buys and Sells

The breakdown on which companies' numbers are easiest to swallow.

Wed Aug 19

NL

Article

EBCapitalMarkets published an article 3:24 PM

3 Low-Price Biotech Stocks That Could Pop or Drop in 2016

Agenus Inc., Array BioPharma, and Idera Pharmaceuticals are expecting to release data from cancer drug trials in the coming year.

NL

Article

EBCapitalMarkets published an article 10:30 AM

Billionaires Are Bailing on These Stocks

Warren Buffett, George Soros, and Carl Icahn sold shares in these companies last quarter.

Tue Aug 18

NL

Article

EBCapitalMarkets published an article 5:12 PM

Kite Reassures Investors, Yet Shares Slip -- What Gives?

Kite says its CAR-T therapy remains on track, but investors still worry about an accelerated timeline for approval.

NL

Article

EBCapitalMarkets published an article 4:16 PM

Is Esperion's Good News Actually Bad?

The FDA says Esperion won't need a cardiovascular outcomes trial, yet shares sink 15%.

NL

Article

EBCapitalMarkets published an article 2:07 PM

A $25 Billion Hedge Fund Just Made AbbVie One of Its Biggest Bets

AbbVie Inc. could end up sidestepping lost sales tied to an expiring patent on Humira in 2017.

NL

Article

EBCapitalMarkets published an article 11:33 AM

3 Stocks Billionaires Are Buying

Discovering Warren Buffett, George Soros, and Carl Icahn's second-quarter stock buys.

Mon Aug 17

NL

Article

EBCapitalMarkets published an article 1:20 PM

Why Achillion Pharmaceuticals Jumped 10% Today

RA Capital Management has shifted from selling Achillion's shares to buying them, suggesting the worst may be over for this company.

Fri Aug 14

NL

Article

EBCapitalMarkets published an article 5:00 PM

Mutual Funds: Understanding the Pros and Cons of This Investing Option

One Fool explains what you need to know about mutual funds.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 64.40
Player Rank 26761 out of 75175
Score 160.96
Score Change Today -5.50
Accuracy 52.94%
Active Picks 34
Total Picks 34
Best Pick MNST (+102.39)
Worst Pick SFM (-64.58)
Average Score per Pick 4.73
Charms Earned 6
Highest Rated Favorite No Favorites Selected
Go to TMFEBCapital’s CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show TMFEBCapital’s 10 Latest Posts